Dewey Steadman | Head, IR |
Martine Rothblatt | Chairperson and CEO |
Michael Benkowitz | President and COO |
Leigh Peterson | SVP, Product Development |
James Edgemond | CFO and Treasurer |
Eun Yang | Jefferies |
Liana Moussatos | Wedbush Securities |
Hartaj Singh | Oppenheimer & Company |
Joe Thome | Cowen & Company |
Good morning, and welcome to the United Therapeutics Corporation First Quarter 2021 Earnings Call. My name is Phyllis, and I will be your conference operator today. [Operator Instructions] I will now turn the conference call over to Mr. Dewey Steadman, Head of Investor Relations at the United Therapeutics.
Good morning.